(Q45306356)

English

Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice (English)

1 reference

Europe PubMed Central

11 December 2017

Huntington's disease

0 references

0 references

Mahmoud A. Pouladi

1

1 reference

Europe PubMed Central

11 December 2017

Stefanie Butland

7

1 reference

Europe PubMed Central

11 December 2017

Amber L Southwell

object named as

Amber L Southwell

5

0 references

Michael R. Hayden

object named as

Michael R Hayden

11

0 references

author name string

Lisa M Stanek

2

1 reference

Europe PubMed Central

11 December 2017

Yuanyun Xie

3

1 reference

Europe PubMed Central

11 December 2017

Sonia Franciosi

4

1 reference

Europe PubMed Central

11 December 2017

Yu Deng

6

1 reference

Europe PubMed Central

11 December 2017

Weining Zhang

8

1 reference

Europe PubMed Central

11 December 2017

Seng H Cheng

9

1 reference

Europe PubMed Central

11 December 2017

Lamya S Shihabuddin

10

1 reference

Europe PubMed Central

11 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

9 February 2012

1 reference

Europe PubMed Central

11 December 2017

Human Molecular Genetics

1 reference

Europe PubMed Central

11 December 2017

21

1 reference

Europe PubMed Central

11 December 2017

10

1 reference

Europe PubMed Central

11 December 2017

2219-2232

1 reference

Europe PubMed Central

11 December 2017

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Riluzole in Huntington's disease: a 3-year, randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

A method and server for predicting damaging missense mutations

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

A second generation human haplotype map of over 3.1 million SNPs

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

dbSNP: the NCBI database of genetic variation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

cisRED: a database system for genome-scale computational discovery of regulatory elements

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

In silico detection of sequence variations modifying transcriptional regulation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Most mammalian mRNAs are conserved targets of microRNAs

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Body weight is modulated by levels of full-length huntingtin

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Transcriptional abnormalities in Huntington disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Polyglutamine diseases: a transcription disorder?

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Diverse psychotomimetics act through a common signaling pathway

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Identifying polyglutamine protein species in situ that best predict neurodegeneration

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Mutations in the TIGR gene in familial primary open-angle glaucoma in Japan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

RNA structure of trinucleotide repeats associated with human neurological diseases

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

CAG repeats mimic CUG repeats in the misregulation of alternative splicing

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Assessing antidepressant activity in rodents: recent developments and future needs

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDS037

21 January 2018

Identifiers

10.1093/HMG/DDS037

1 reference

Europe PubMed Central

11 December 2017

1 reference

Europe PubMed Central

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45306356&oldid=2074327057"